Martin Javier San

Martin Javier San, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Arrowhead Pharmaceuticals, Inc. and LeonaBio, Inc. Over a trading history stretching from 19 November 2020 to 4 March 2026, the count stands at 21 filings.

On the market, this insider has only sold: 15 sales, €3.7M in total. The rest of the record consists of 2 share grants and 4 option exercises. So far in 2026, the count stands at no purchases and 2 sales.

The record was last updated on 5 March 2026 with an open-market sale (€7,954) in LeonaBio, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.